New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Kowsar

Anticoagulation in Lower Risk Atrial Fibrillation: A two Edged Sword

Reza Kiani 1 , *
Author Information
1 Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
This article has a relationship commentary-article with this article : Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation.
Article information
  • Research in Cardiovascular Medicine: February 24, 2013, 2 (1); 74-5
  • Published Online: February 24, 2013
  • Article Type: Letter
  • Received: July 23, 2012
  • Revised: July 26, 2012
  • Accepted: July 27, 2012
  • DOI: 10.5812/cardiovascmed.7380

To Cite: Kiani R. Anticoagulation in Lower Risk Atrial Fibrillation: A two Edged Sword, Res Cardiovasc Med. 2013 ;2(1):74-5. doi: 10.5812/cardiovascmed.7380.

Copyright: Copyright © 0, Research in Cardiovascular Medicine. .
Footnotes
References
  • 1. Arya A, Kircher S, Müssigbrodt A, Eitel C, Sommer P, Hindricks G. Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation. Res Cardiovasc Med. 2012; 1(1): 3-9
  • 2. Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost. 2011; 9(1): 39-48[DOI][PubMed]
  • 3. Poli D, Antonucci E, Grifoni E, Paoletti O, Rancan E, Dentali F, et al. Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion. Thromb Res. 2012; 129(5): 588-90[DOI][PubMed]
  • 4. Rose AJ, Ozonoff A, Henault LE, Hylek EM. Warfarin for atrial fibrillation in community-based practise. J Thromb Haemost. 2008; 6(10): 1647-54[DOI][PubMed]
  • 5. Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol. 2012; 110(3): 453-60[DOI][PubMed]
  • 6. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009; 374(9689): 534-42[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .